Sequential Treatment with Pazopanib and Everolimus in Metastatic Renal Cell Carcinoma.

about

A network meta-analysis of short-term efficacy of different single-drug targeted therapies in the treatment of renal cell carcinoma.Network meta-analysis of second-line treatment in metastatic renal cell carcinoma: efficacy and safety.

P2860

Q47143379-9679034A-B3C5-47F0-9B2D-04862B94083C Q47813600-20FAC193-3B50-4061-A54D-F587D8E596D3

P2860

Sequential Treatment with Pazopanib and Everolimus in Metastatic Renal Cell Carcinoma.

Item

http://www.wikidata.org/entity/Q38642100

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Sequential Treatment with Pazopanib and Everolimus in Metastatic Renal Cell Carcinoma.

@en

type

Item

label

Sequential Treatment with Pazopanib and Everolimus in Metastatic Renal Cell Carcinoma.

@en

prefLabel

Sequential Treatment with Pazopanib and Everolimus in Metastatic Renal Cell Carcinoma.

@en

P1476

Sequential Treatment with Pazopanib and Everolimus in Metastatic Renal Cell Carcinoma

@en

P2093

Carmine D'Aniello

http://www.w3.org/2001/XMLSchema#string

Clementina Savastano

http://www.w3.org/2001/XMLSchema#string

Fernando De Vita

http://www.w3.org/2001/XMLSchema#string

Giacomo Cartenì

http://www.w3.org/2001/XMLSchema#string

Maria A Porricelli

http://www.w3.org/2001/XMLSchema#string

Maria M Laterza

http://www.w3.org/2001/XMLSchema#string

Massimiliano Berretta

http://www.w3.org/2001/XMLSchema#string

Salvatore Pisconti

http://www.w3.org/2001/XMLSchema#string

Sarah Scagliarini

http://www.w3.org/2001/XMLSchema#string

P2860

Nivolumab in the treatment of advanced renal cell carcinoma: clinical trial evidence and experience

Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial

Pazopanib versus sunitinib in metastatic renal-cell carcinoma.

Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study.

External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study

Pazopanib for metastatic pulmonary epithelioid hemangioendothelioma-a suitable treatment option: case report and review of anti-angiogenic treatment options.

Surgical intervention for pulmonary metastases

Pazopanib in Metastatic Renal Cancer: A "Real-World" Experience at National Cancer Institute "Fondazione G. Pascale"

Outcomes of patients with metastatic clear-cell renal cell carcinoma treated with pazopanib after disease progression with other targeted therapies

New treatment approaches in renal cell carcinoma.

P304

484

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FPHAR.2017.00484

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-07-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28775690

http://www.w3.org/2001/XMLSchema#string

P932

5517440

http://www.w3.org/2001/XMLSchema#string

Sequential Treatment with Pazopanib and Everolimus in Metastatic Renal Cell Carcinoma.

about

P2860

P2860

Sequential Treatment with Pazopanib and Everolimus in Metastatic Renal Cell Carcinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932